Active Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES
AI Summary
The FDA seeks a contract for a Siemens modeling and simulation platform license for advanced lyophilization process modeling. The software must meet specific technical requirements, including nonlinear predictive control and high-fidelity dynamic simulation. The contractor will also provide maintenance, technical support, and training. Interested parties should review the attached RFQ document for complete details.
The objective is to establish a new contract for Siemens modeling and simulation platform license, featuring advanced process modeling.
FDA's OPQR has a requirement to obtain an advanced lyophilization process modeling and simulation platform to study emerging pharmaceutical manufacturing technologies. For Quoter’s software to be deemed acceptable, the following salient characteristics shall be met:
Lyophilization Modeling Toolbox
• Nonlinear Predictive Control (NL) for Lyophilization: Utilizes a highly parallelized, equation-oriented architecture optimized for high-performance computing (HPC) to perform large-scale, high-fidelity predictive modeling of time-dependent lyophilization cycles.
• Operational Intelligence & Data Integration: Must include a base system (such as XHQ) capable of aggregating and visualizing real-time operational data from multiple manufacturing sources to support "Digital Twin" validation.
• High-Fidelity Dynamic Simulation: Capable of simulating transient process events and complex equipment dynamics—including freezing, primary drying, and secondary drying—using first-principles mathematical equations rather than empirical data.
• Advanced Material & Thermodynamic Property Architecture: Supports the modeling of complex pharmaceutical formulations through comprehensive databases for excipients and APIs to track critical properties like moisture content and chemical purity throughout the stabilization process.
• Automated Global System Analysis (GSA): Built-in mathematical tools to perform parameter estimation from experimental data and Global Sensitivity Analysis (GSA) to identify influential process parameters and validate Quality by Design (QbD) design spaces.
• Customizable Modeling Environment & API: Features an open, equation-oriented language for creating custom first-principles models from scratch, complemented by a robust Application Programming Interface (API) for integration with external data systems like Python, Excel, or Electronic Lab Notebooks.
• Scalable Enterprise Access: Supports flexible licensing types including "Named User" for specific researchers and "Small System" base configurations to manage data exchange across physical or virtual assets.
• Regulatory-Grade Maintenance and Support: Provided through a multi-year subscription model that includes continuous software enhancement, technical support, and alignment with established Licensed Software Designation Agreements (LSDA).
Maintenance and Technical Support
At minimum the contractor must:
• Provide support via email and/or web conference.
• Licenses shall include maintenance, support, and any upgrades necessary to maintain the system.
• Provide one day of project support.
Training
The Contractor shall provide:
• Access to online training material in Altair resources
Please review the attached RFQ_FDA-75F40126Q00155 document for all details.
GPROMS LYOPHILIZATION MODELING TOOLBOX (OR EQUAL) is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.
SamSearch Platform
AI-powered intelligence for the right opportunities, the right leads, and the right time.